The report highlights the company's commitment to sustainable development and corporate social responsibility. Astellas outlines its key initiatives in areas such as environmental conservation, safety, and employee welfare. The report also details the company's progress in implementing a CSR-based management system, including the development of a Charter of Corporate Conduct and a Code of Conduct. Notable highlights from the year include the establishment of Astellas Pharma Chemicals Co., Ltd., the closure of the Osaka Plant, and the sale of the OTC business subsidiary Zepharma Inc. to a firm outside the Group.
Issuing Company Astellas Pharma Inc.
Report Type Sustainability Report
Report Language EN
Report Filesize 4.48 MB
No. of Pages 56 pages
Reporting periodApril 1, 2005-March 31, 2006
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI; SASB; UNSDGs
Materiality Assessmenttrue